课题基金 / 基金详情

Tumor oxygenation to in crease sensitivity to anti-cancerous drug by using artificial oxygen carrier

Tumor oxygenation to in crease sensitivity to anti-cancerous drug by using artificial oxygen carrier
使用人工氧载体进行肿瘤氧合以增加抗癌药物的敏感性
批准号:
10470247
负责人:
KOBAYASHI Koichi
金额:
$8.38万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

KOBAYASHI Koichi的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer cells are often resistant to anti-cancerous agents. One of the reasons of this phenomenon is cancer cells are hypoxic.To study if artificial oxygen carriers (AOCs) increases sensitivity of tumor cells to anti-cancerous agents, following experiments were designed.Yoshida sarcoma cells (LY-80) were inplanted to the back muscle of rats.Quantative analysis of blood flow in the tumors was performed by microsphere method.Using Oxyspot method, tissue oxygen pressure of the tumors (PtO_2) was evaluated. The AOCs used were hemoglobin vesicles (HbV), albumin-heme (AH) and perfluorocarbons (PFCs). They were intravenously injected. As control, Ractate Ringer solution and 5% albumin solution were injected. Among AOCs, only AH increased PtO_2 upto 130% of the basal value. In another groups PtO_2 was not increased, probably become they scavenged nitric oxide to cause microvascular contraction to decrease blood flow.To resolve this mechanism further experiments are needed to study microvascular circulation in the tumors. Also arterial infusion of the AOCs and anti-cancerous drugs must be evaluated.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Eishun Tsuchida,Koichi Kobayashi,et.al.: "Blood Substitutes Present and Future Perspectives" ELISVER, 390(315〜326)
Eishun Tsuchida、Koichi Kobayashi 等人:“血液替代品的现状和未来展望”ELISVER,390(315-326)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
小林 紘一: "集中治療領域での人工血液の現状と将来"集中治療. 12(1). 65-74 (2000)
Koichi Kobayashi:“重症监护中人造血液的现状和未来”重症监护 12(1)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Eishun Tsuchida,Koichi Kobayashi,et.al.: "Blood Substitutes Present and Future Perspectives" ELISVER, 390(171〜184)
Eishun Tsuchida、Koichi Kobayashi 等人:“血液替代品的现状和未来展望”ELISVER,390(171-184)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
小林紘一: "集中治療領域での人工血液の現状と将来"集中治療. 12(1). 65-74 (2000)
Koichi Kobayashi:“重症监护中人造血液的现状和未来”重症监护 12(1)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fiber reinforced mortar with high durability and high ductility for shotcreting
  • 批准号:
    25420458
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.58万
  • 财政年份:
    2013
  • 负责人:
    KOBAYASHI Koichi
  • 依托单位:
Regulation of chloroplast differentiation during sink/source conversion
  • 批准号:
    24770055
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $3.0万
  • 财政年份:
    2012
  • 负责人:
    KOBAYASHI Koichi
  • 依托单位:
Control of Stochastic Hybrid Systems and Its Applications to Systems Biology
In vivo measurement of 3D load transfer mechanism in the lower extremity
  • 批准号:
    22560074
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2010
  • 负责人:
    KOBAYASHI Koichi
  • 依托单位: